USFDA nod to Zydus Lifesciences Migraine drug Topiramate Extended Release Ruchika Sharma1 Dec 2022 11:16 AM ISTThe drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, India.
Ultra-high-res MRI reveals migraine brain changes Dr. Kamal Kant Kohli27 Nov 2022 8:00 PM ISTCHICAGO- For the first time, a new study has identified enlarged perivascular spaces in the brains of migraine sufferers. Results of the study will be...
Eli Lilly ordered to pay Rs 1444 crore to Teva Pharma in US migraine drug patent trial Ruchika Sharma10 Nov 2022 2:00 PM ISTThe jury also found that Lilly infringed the patents willfully and rejected its argument that the patents were invalid.
Migraine tied to increased anxiety and depression among children and adolescents: JAMA Aditi3 Nov 2022 9:45 AM ISTCanada: A recent original investigation published in JAMA Paediatrics concluded that there is an increased risk of anxiety and depressive symptoms in...
Having a Migraine shoots up future risk of dementia Dr.Niharika Harsha B9 Oct 2022 7:30 PM ISTA recent study found that migraine is associated with an increased risk of subsequent dementia. The study was published in The Journal of Headache and...
Greater occipital nerve blocks may alleviate photophobia brought on by migraines Dr. Kamal Kant Kohli1 Oct 2022 11:15 AM ISTSPAIN: According to a research study published in the Journal of Neuro-Ophthalmology, greater occipital nerve block reduces migraine-related...
Ubrogepant best treatment option for relieving mild migraine pain: Study Jacinthlyn Sylvia1 Sept 2022 10:15 AM ISTUSA: A new study published in Neurology found that ubrogepant treatment against mild migraine pain resulted in greater pain relief, symptomatic...
Soy isoflavones supplementation helps fight migraine in women: BMC Jacinthlyn Sylvia8 Aug 2022 9:30 AM ISTA new study published in BMC Nutrition Journal suggests that supplementing with soy isoflavones may be thought of as an additional therapy for...
Cipla gets CDSCO panel nod to study Rizatriptan Benzoate Orally Disintegrating Tablet Rahul Verma4 Aug 2022 6:00 PM ISTGranting approval to conduct bioequivalence (BE) study of Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, the Subject Expert Committee (SEC)...
Cipla Secure CDSCO Panel Nod To Study Rizatriptan Benzoate Orally Disintegrating Tablet Dr. Divya Colin3 Aug 2022 6:00 PM ISTNew Delhi: Granting approval to conduct bioequivalence (BE) study of Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, the Subject Expert...
External concurrent occipital and trigeminal neurostimulation relieves migraine pain: Study Jacinthlyn Sylvia21 July 2022 9:15 AM ISTUSA: In a randomized environment, external concurrent occipital and trigeminal neurostimulation offered quick and lasting relief and freedom from...
AbbVie seeks EMA approval for Atogepant for prophylaxis treatment of Migraine Ruchika Sharma19 July 2022 1:45 PM ISTAtogepant is an orally administered, CGRP receptor antagonist (gepant) specifically developed for the prophylaxis treatment of migraine.
